Literature DB >> 24146379

Membrane associated carbonic anhydrase IV (CA IV): a personal and historical perspective.

Abdul Waheed1, William S Sly.   

Abstract

Carbonic anhydrase IV is one of 12 active human isozymes and one of four expressed on the extracellular surfaces of certain endothelial and epithelial cells. It is unique in being attached to the plasma membrane by a glycosyl-phosphatiydyl-inositol (GPI) anchor rather than by a membrane-spanning domain. It is also uniquely resistant to high concentrations of sodium dodecyl sulfate (SDS), which allows purification from tissues by inhibitor affinity chromatography without contamination by other isozymes. This unique resistance to SDS and recovery following denaturation is explained by the two disulfide bonds. The 35-kDa human CA IV is a "high activity" isozyme in CO2 hydration activity, like CA II, and has higher activity than other isozymes in catalyzing the dehydration of HCO3 (-). Human CA IV is also unique in that it contains no oligosaccharide chains, where all other mammalian CA IVs are glycoproteins with one to several oligosaccharide side chains.Although CA IV has been shown to be active in mediating CO2 and HCO3 (-) transport in many important tissues like kidney and lung, and in isolated cells from brain and muscle, the gene for CA IV appears not to be essential. The CA IV knockout mouse produced by targeted mutagenesis, though slightly smaller and produced in lower than expected numbers, is viable and has no obvious mutant phenotype. Conversely, several dominant negative mutations in humans are associated with one form of reitinitis pigmentosa (RP-17), which we attribute to unfolded protein accumulation in the choreocapillaris, leading to apoptosis of cells in the overlying retina.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24146379     DOI: 10.1007/978-94-007-7359-2_9

Source DB:  PubMed          Journal:  Subcell Biochem        ISSN: 0306-0225


  9 in total

1.  Downregulation of carbonic anhydrase IV contributes to promotion of cell proliferation and is associated with poor prognosis in non-small cell lung cancer.

Authors:  Jian Chen; Lijuan Hu; Fan Zhang; Junjun Wang; Jie Chen; Yumin Wang
Journal:  Oncol Lett       Date:  2017-08-10       Impact factor: 2.967

2.  Identification of Human Brain Proteins for Bitter-Sweet Taste Perception: A Joint Proteome-Wide and Transcriptome-Wide Association Study.

Authors:  Wenming Wei; Bolun Cheng; Dan He; Yijing Zhao; Xiaoyue Qin; Qingqing Cai; Na Zhang; Xiaoge Chu; Sirong Shi; Feng Zhang
Journal:  Nutrients       Date:  2022-05-23       Impact factor: 6.706

3.  Carbonic anhydrase IV is expressed on IL-5-activated murine eosinophils.

Authors:  Ting Wen; Melissa K Mingler; Benjamin Wahl; M Eyad Khorki; Oliver Pabst; Nives Zimmermann; Marc E Rothenberg
Journal:  J Immunol       Date:  2014-05-07       Impact factor: 5.422

4.  Monomeric C-reactive protein and inflammation in age-related macular degeneration.

Authors:  Kathleen R Chirco; S Scott Whitmore; Kai Wang; Lawrence A Potempa; Jennifer A Halder; Edwin M Stone; Budd A Tucker; Robert F Mullins
Journal:  J Pathol       Date:  2016-09-19       Impact factor: 7.996

5.  Role of carbonic anhydrases in skin wound healing.

Authors:  Harlan Barker; Marleena Aaltonen; Peiwen Pan; Maria Vähätupa; Pirkka Kaipiainen; Ulrike May; Stuart Prince; Hannele Uusitalo-Järvinen; Abdul Waheed; Silvia Pastoreková; William S Sly; Seppo Parkkila; Tero Ah Järvinen
Journal:  Exp Mol Med       Date:  2017-05-19       Impact factor: 8.718

6.  RNA-Seq based genome-wide analysis reveals loss of inter-chromosomal regulation in breast cancer.

Authors:  Jesús Espinal-Enríquez; Cristóbal Fresno; Guillermo Anda-Jáuregui; Enrique Hernández-Lemus
Journal:  Sci Rep       Date:  2017-05-11       Impact factor: 4.379

7.  Novel hybrid action of GABA mediates inhibitory feedback in the mammalian retina.

Authors:  James C R Grove; Arlene A Hirano; Janira de Los Santos; Cyrus F McHugh; Shashvat Purohit; Greg D Field; Nicholas C Brecha; Steven Barnes
Journal:  PLoS Biol       Date:  2019-04-01       Impact factor: 8.029

8.  Acetazolamide reduces exercise capacity following a 5-day ascent to 4559 m in a randomised study.

Authors:  Arthur R Bradwell; Kimberley Ashdown; Carla Rue; John Delamere; Owen D Thomas; Samuel J E Lucas; Alex D Wright; Stephen J Harris; Stephen D Myers
Journal:  BMJ Open Sport Exerc Med       Date:  2018-01-23

9.  Effects of hub genes on the clinicopathological and prognostic features of lung adenocarcinoma.

Authors:  Dong-Hu Yu; Jing-Yu Huang; Xiao-Ping Liu; Xiao-Lan Ruan; Chen Chen; Wei-Dong Hu; Sheng Li
Journal:  Oncol Lett       Date:  2019-12-09       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.